UK markets close in 5 hours 39 minutes

Merck & Co., Inc. (0QAH.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
89.70+0.19 (+0.22%)
As of 06:10PM GMT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3N/A
S&P500 52-week change 3-12.21%
52-week high 389.48
52-week low 389.12
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.54B
% held by insiders 10.10%
% held by institutions 177.66%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.76
Trailing annual dividend yield 33.08%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 24.49%
Operating margin (ttm)34.69%

Management effectiveness

Return on assets (ttm)11.96%
Return on equity (ttm)34.46%

Income statement

Revenue (ttm)59.28B
Revenue per share (ttm)23.41
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)42.08B
Net income avi to common (ttm)14.52B
Diluted EPS (ttm)5.59
Quarterly earnings growth (yoy)-19.70%

Balance sheet

Total cash (mrq)13.19B
Total cash per share (mrq)5.2
Total debt (mrq)31.99B
Total debt/equity (mrq)69.44
Current ratio (mrq)1.47
Book value per share (mrq)18.12

Cash flow statement

Operating cash flow (ttm)19.09B
Levered free cash flow (ttm)12.69B